A novel dinuclear diaminoplatinum(II) glutathione macrochelate

Angewandte Chemie - International Edition

Volumn 38, Issue 19, 1999, Pages 2949-2951

  Del Socorro Murdoch, Piedad ^a   Kratochwil, Nicole A ^a   Parkinson, John A ^a   Patriarca, Marina ^a   Sadler, Peter J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Antitumor agents; Bioinorganic chemistry; Glutathione; NMR spectroscopy; Platinum

Indexed keywords

CISPLATIN DERIVATIVE; GLUTATHIONE DERIVATIVE; PLATINUM DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER; CANCER CHEMOTHERAPY; DRUG DNA INTERACTION; DRUG ISOLATION;

EID: 0033523616     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-3773(19991004)38:19<2949::AID-ANIE2949>3.0.CO;2-Q     Document Type: Article

References (21)

1. A. Meister in Glutathione. Chemical, biochemical, and medical aspects (Eds.: D. Dolphin, O. Avramovic, R. Poulson), Wiley, New York, 1989, pp. 1-48.
2. J. Reedijk, J. M. Teuben in Cisplatin - chemistry and biochemistry of a leading anticancer drug (Ed.: B. Lippert). WILEY-VCH, Weinheim, 1999, pp. 339-362. See also section 3 of Z. Guo, P. J. Sadler, Angew. Chem. 1999, 111, 1610-1630; Angew. Chem. Int. Ed. 1999, 38, 1512-1531.
3. J. Reedijk, J. M. Teuben in Cisplatin - chemistry and biochemistry of a leading anticancer drug (Ed.: B. Lippert). WILEY-VCH, Weinheim, 1999, pp. 339-362. See also section 3 of Z. Guo, P. J. Sadler, Angew. Chem. 1999, 111, 1610-1630; Angew. Chem. Int. Ed. 1999, 38, 1512-1531.
4. J. Reedijk, J. M. Teuben in Cisplatin - chemistry and biochemistry of a leading anticancer drug (Ed.: B. Lippert). WILEY-VCH, Weinheim, 1999, pp. 339-362. See also section 3 of Z. Guo, P. J. Sadler, Angew. Chem. 1999, 111, 1610-1630; Angew. Chem. Int. Ed. 1999, 38, 1512-1531.
5. S. J. Berners-Price, P. W. Kuchel, J. Inorg. Biochem. 1990, 38, 327-345.
6. a) T. Ishikawa, C. D. Wright, H. Ishizuka, J. Biol. Chem. 1994, 269, 29085-29093;
7. b) T. Ishikawa, J.-J. Bao, Y. Yamane, K. Akimaru, K. Frindrich, C. D. Wright, M. T. Kuo, J. Biol. Chem. 1996, 271, 14981-14988.
8. D. T. Dorr in Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy 2 (Eds.: H. M. Pinedo, J. H. Schornagel), Plenum Press, New York, 1996, pp. 131-154.
9. T. G. Appleton, J. W. Connor, J. R. Hall, P. D. Prenzler, Inorg. Chem. 1989, 28, 2030-2037.
10. T. G. Appleton, Coord. Chem. Rev. 1997, 166, 313-359.
11. K. C. Streveler, C. M. Jensen, Inorg. Chem. 1993, 32, 2608-2609.
12. A. Bernareggi, L. Torti, R. M. Facino, M. Carini, G. Depta, B. Casetta, N. Farrell, S. Spadacini, R. Ceserani, S. Tognella, J. Chromatogr. 1995, 669, 247-263.
13. S. J. Berners-Price, P. J. Sadler, Coord. Chem. Rev. 1996, 151, 1-40.
14. The resonance also remained present up to pH 11.5 during the course of a pH titration of complex 3 when all other NH resonances had disappeared through fast exchange with the solvent.
15. A. K. Fazlur-Rahman, J. G. Verkade, Inorg. Chem. 1992, 31, 2064-2069.
16. E. L. M. Lempers, K. Inagaki, J. Reedijk, Inorg. Chim. Acta 1988, 152, 201-207.
17. N. Ohta, K. Inagaki, H. Muta, T. Yotsuyanagi, T. Matsuo, Int. J. Pharmaceut. 1998, 161, 15-21.
18. N. Ohta, D. Chen, S. Ito, T. Futo, T. Yotsuyanagi, K. Ikeda, Int. J. Pharmaceut. 1995, 118, 85-93.
19. a) E. Zang, P. J. Sadler, Synthesis 1997, 410-414;
20. b) L. T. Ellis, H. M. Er, T. W. Hambley, Aust. J. Chem. 1995, 48, 793-806.
21. S. J. Berners-Price, U. Frey, J. D. Ranford, P. J. Sadler, J. Am. Chem. Soc. 1993, 115, 8649-8659.